InfuSystem Reports Strong Q1 2025 Financial Results

InfuSystem Holdings, Inc. ( (INFU) ) has released its Q1 earnings. Here is a breakdown of the information InfuSystem Holdings, Inc. presented to its investors.

InfuSystem Holdings, Inc., a prominent healthcare service provider, specializes in facilitating outpatient care for durable medical equipment manufacturers and healthcare providers, with operations across the United States and Canada. The company operates through two main platforms: Patient Services and Device Solutions, focusing on Oncology, Pain Management, and Wound Therapy.

In its first quarter of 2025, InfuSystem reported record net revenues of $34.7 million, marking a 9% increase from the previous year. Despite a net loss of $0.3 million, the company achieved a significant 64% rise in adjusted EBITDA to $6.3 million, with an expanded margin of 18.2%. The company’s strong performance was driven by growth in its core business areas and strategic focus on operational efficiency.

Key financial highlights include a 12% increase in Patient Services net revenue to $20.8 million and a 4% rise in Device Solutions net revenue to $13.9 million. Gross profit improved by 16% to $19.2 million, with a gross margin increase to 55.2%. The company also repurchased approximately $3.0 million in stock, reflecting confidence in its financial health and future prospects.

Looking ahead, InfuSystem’s management remains optimistic about continued growth, reaffirming its annual guidance for 2025 with expected net revenue growth in the 8% to 10% range and adjusted EBITDA margins in the high teens. The company is poised to build on its momentum, focusing on capital-efficient growth and strategic investments under new leadership.